Steven Jandrich - Inspire Medical President

INSP Stock  USD 158.79  4.42  2.86%   

President

Mr. Steven Jandrich serves as Chief Compliance Officer and Vice President, Human Resources of the Company since September 2017. From May 2015 to September 2017, Mr. Jandrich served as Vice President, Human Resources for Link Snacks, Inc., a multinational retail snack producer, where he led human resources functions including talent management and employee relations. From April 2001 to April 2015, Mr. Jandrich was an employee of St. Jude Medical, Inc., and from January 2013 to April 2015 Mr. Jandrich served as its Vice President of Commercial Operations and was responsible for establishing its global sales training program since 2021.
Age 57
Tenure 3 years
Professional MarksMBA
Address 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416
Phone844 672 4357
Webhttps://www.inspiresleep.com
Jandrich holds a B.B.A. and M.B.A., both from the University of St. Thomas.

Inspire Medical Management Efficiency

The company has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0288) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/01/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 06/01/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.
The company currently holds 24.85 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Inspire Medical Systems has a current ratio of 5.51, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Inspire Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Inspire Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inspire Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inspire to invest in growth at high rates of return. When we think about Inspire Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

PRESIDENT Age

Gary LongR1 RCM Inc
53
John SparbyR1 RCM Inc
48
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Inspire Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 485 people. Inspire Medical Systems (INSP) is traded on New York Stock Exchange in USA. It is located in 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 and employs 1,011 people. Inspire Medical is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

Inspire Medical Systems Leadership Team

Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Georgia GarinoisMelenikiotou, Independent Director
Megan CPA, Director Reporting
Timothy Herbert, President, Chief Executive Officer, Director
Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources
Philip Ebeling, Chief Operating Officer
Ezgi Yagci, Vice Relations
Andreas Henke, Senior Europe
Casey Tansey, Independent Director
Richard Buchholz, Chief Financial Officer
Kathy Sherwood, Senior Access
Martin Abrams, Vice Experience
Gary Ellis, Independent Director
John Rondoni, Chief Officer
Shawn McCormick, Independent Director
Carlton Weatherby, Chief Officer
Randall Ban, Senior Vice President Global Sales and Marketing
Dana Mead, Independent Director
Shelley Broader, Independent Director
Ivan Lubogo, Senior Sales
Georgia Melenikiotou, Independent Director
MD FAAOS, Chief Officer
Marilyn Nelson, Independent Chairman of the Board
Jerry Griffin, Independent Director
Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary

Inspire Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Inspire Stock analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.682
Earnings Share
(0.52)
Revenue Per Share
22.454
Quarterly Revenue Growth
0.282
Return On Assets
(0.04)
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.